The pharmacokinetic behaviour of alcuronium was studied in three patients undergoing resection of an aortic aneurysm, and in another two patients undergoing total hip replacement (group I). A control group of five elderly patients undergoing relatively minor surgery was included (group II). In group I patients, the values of the pharmacokinetic parameters such as plasma clearance, elimination half-life and the apparent volume of distribution of the drug were found to be comparable to those obtained in normal young patients in previous studies. The group II patients, however, were found to have a prolonged elimination half-life as a result of reduced plasma clearance, possibly an age-related effect. The differences between these two groups of patients may be explained by the differences in the extent of haemorrhage and fluid replacement or changes in blood circulation, or both. However, alcuronium must still be used cautiously in both groups of patients, especially in the light of a recent finding that patients undergoing aortic reconstructive surgery have a high frequency of functional renal failure after operation.
with minimal blood loss was included in this study to discriminate between the effects of blood loss and age on the disposition of the alcuronium.
PATIENTS AND METHODS

Patients
Three patients undergoing reconstructive aortic surgery and two undergoing total hip replacement were studied. Another five elderly patients of matching age undergoing general anaesthesia for surgery without major blood loss were included as control subjects. Before the operation, informed consent was obtained from each patient. The hepatic and renal functions of each patient were assessed by clinical and biochemical tests and individuals with significant renal and hepatic disease were excluded. Characteristics of the patients and the types of operation are shown in table I.
Anaesthetic procedures
Premedication consisted of papaveretum i.m. and Mist. Mag. Trisil. 15 ml by mouth 1 h before the induction of anaesthesia with fentanyl and thiopentone. Neuromuscular blockade was produced with alcuronium 0.30 mgkg"
1 . When necessary, papaveretum in incremental doses, and alcuronium in doses of one-fourth the initial dose, were added. Anaesthesia was maintained with a combination of 70% nitrous oxide in oxygen.The lungs were ventilated mechanically and serial blood samples taken to monitor ventilation and acid-base status. In pa- ticnts undergoing resection of an aortic aneurysm, the times of the application and release of the aortic clamp were noted. Before induction, a central venous pressure (CVP) catheter, or a pulmonary artery catheter was inserted, through which all blood samples were drawn, and via which central venous pressure (CVP), or pulmonary artery pressure (PAP) were measured. At the end of each operation, residual neuromuscular blockade was antagonized with neostigmine and atropine i.v.
Blood sampling
Blood samples were collected from the central venous catheter, or the pulmonary artery catheter. A control blood sample was collected before the administration of the initial dose of neuromuscular blocker. Further samples were collected at 3, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 180, 240, 360 , and 480 min after the administration of alcuronium.
When maintenance doses of the drug were required, identical blood sampling procedures were repeated after each additional dose, whenever possible. Blood samples were centrifuged after collection and the plasma separated and stored at -20°C until analysis. In all patients, lost blood was drained into suction bottles. The volumes of blood lost during and after the operation were estimated, and the volumes of fluid given were noted.
Alcuronium assay
Blood concentrations of alcuronium were determined by an HPLC method developed recently by Parkin (1981) . This method involved the addition of 1 ml of plasma to 1 ml of potassium dihydrogen phosphate 0.25 mollitre" 1 , 2 ml of 2.5% picric acid and 1 ml of tubocurarine 7.5ngml~l as internal standard. The mixture was then extracted by 5 ml of 15% isopropyl alcohol in dichloromethane. The calibration curve obtained was linear over the range of 0.6-5 ng ml"
1 .
Pharmacokinetic analysis
The plasma concentration-time curve for each patient was analysed by a weighted iterative nonlinear least squares regression using the computer program Nonlin (Metzler, Elfring and McEwen, 1974) , modified to rim on a mini-computer (Bourne and Wright, 1981) . Data points were fitted by both a bi-exponential and a tri-exponential equation. The selection of the appropriate equation to describe alcuronium disposition was based on the criteria suggested by Boxenbaum, Riegelman and Elashoff, (1974) , and any computer fit was accepted as valid only if the exponent values were widely separated (that is, greater than two-to five-fold) (Wagner, 1976) . Model independent parameters were calculated from equations for a mammillary model with central compartment elimination only (Wagner, 1976) . Statistical differences between the two patient groups were compared by the non-parametric Mann-Whitney U test at the 5% level of significance (Freund, 1967) .
RESULTS
The estimated amount of blood lost and fluid replaced in each patient is shown in table II. Patients in group I lost a volume of blood approximately five times that of the control patients (group II), and the volumes of fluid replaced were three times greater in the group I patients. A bi-exponential equation was found adequate to describe the plasma concentration-time data for alcuronium from all the subjects with the exception of three of the group II elderly patients (SE, EV, and NI) where a tri-exponential fit was required. The measured plasma concentrations determined in one patient undergoing aortic aneursym resection (CO) and in one patient undergoing total hip replacement (GO) are shown in figures 1 and 2. The model- independent pharmacokinetic parameters, including the terminal elimination phase half-life (Tj*), plasma clearance (Cl), volume of distribution at steady state (V) and the apparent volume of distribution (V*), are presented in table III. The patients in group II showed a wide range of variation in the elimination half-lives (from 220 to 1407 min) and it should be noted that the terminal half-lives were longer than the sampling times in three of the patients in group II. Unfortunately, because of clinical limitations the sampling times could not be extended. The mean elimination half-life was calculated as the harmonic mean: Boxenbaum and colleagues (1977) suggested that this was more appropriate than the arithmetic mean in the averaging of half-lives, especially when range of variation is great, as in the elderly patients studied. Significant differences were found between the two groups in elimination half-life (Tf) and plasma clearance (Cl), but there were no significant differences in the other measured pharmacokinetic parameters ( fig. 3) .
When the five patients with extensive blood loss (group I) were compared with 15 younger patients (< 65 yr old) studied by Walker, Shanks and Triggs (1980) , no significant differences, in the modelindependent pharmacokinetic parameters 7}*, V 8 , Cl, were found between the two groups (P> 0.05 in all cases) (table IV).
DISCUSSION
Surgical procedures for total hip replacement and aortic aneurysm resection often result in considerable blood loss, and cross-clamping of the abdominal aorta in reconstructive aortic surgery induces frequently a substantial increase in mean arterial pressure, peripheral vascular resistance and myocardial workload. When the aortic clamp is released, a profound and equally deleterious hypotension may develop (Thomson, Eklof and Neglen, 1980) . To prevent hypovolaemia and drastic changes in the circulation, fluid replacement is required. During the continuous blood loss and fluid replacement process, haemodilution would occur and it could be anticipated that the disposition of some drugs might be altered. However, little information is available in man on the effects of normovolaemic haemodilution on drug disposition. One study of four elderly patients undergoing resection of an aortic aneursym showed that the apparent volume of distribution of morphine was 50% greater (4.7 against 3.2 litre" 1 )} and that the elimination half-life was 50% longer (4.5 against 2.9 h~') than that noted in young volunteers. However, the plasma clearance was only slightly lower in these elderly surgical patients (12.4 against 14.7 ml min kg" 1 ) (Stanski, Greenblatt and Lowenstein, 1978) . In contrast, another study found that the elimination half-life of morphine was not changed in the aged (Berkowitz et al., 1975) . Therefore, whether the increase in the volume of distribution and the elimination half-life in the elderly patients in the former study was a result of the effect of age or surgery remains unknown.
In the present study, the apparent volume of distribution (V), the elimination half-life and the plasma clearance of alcuronium in the elderly patients with extensive blood loss were found to be comparable to results obtained previously in younger patients undergoing elective surgery (Walker, Shanks and Triggs, 1980; Raaflaub and Frey, 1972) . On the other hand, in this study, the five normal elderly patients (group II) were found to have a significantly prolonged elimination half-life (7V) and decreased plasma clearance (Cl). Neither the apparent volume of distribution (V), nor the steady-state distribution volume (V**) in this group of patients was significantly different from the previous data obtained by Walker, Shanks and Triggs (1980) .
The differences between our two groups of patients in the values obtained for the elimination half-life and clearance of alcuronium may not be explained totally by the differences in blood loss. The pharmacokinetics of the drug in three out of the five normal elderly patients were found to be better described by a three-compartment than by a two-compartment model. Their plasma concentration-time profiles were characterized by a distinctive rapid distributive and then a slow pseudo-distributive phase followed by terminal elimination (fig. 4) . This phenomenon was not found in the elderly patients in group I with extensive blood loss and substantial fluid replacement: the rate of elimination was more rapid. The pharmacokinctic equilibrium of these latter patients might be disturbed by their surgical condition, for example, the haemorrhage, large volume of replacement fluid, changing hormonal concentrations in response to the stress of surgery, alterations in plasma protein concentrations, or transient changes in cardiac output and arterial pressure. Rose and Coutsoftides (1981) indicated that normovolaemic haemodilution in elderly patients caused an increase in cardiac output to compensate for the diminished oxygen content of the blood. The increase in cardiac output and the concurrent decrease in systemic vascular resistance after haemodilution (Couderc et al., 1982) may enhance renal blood flow and the subsequent elimination of the drug. This finding may be particularly pertinent since, with patients in group I, meticulous care was taken to maintain cardiac output and renal blood flow. The resulting picture may be a consequence of many factors which cannot be delineated separately in the present study. Alcuronium is a water-soluble and completely ionized drug, which is excreted unchanged mainly by the kidney (Raaflaub and Frey, 1972) . It is well known that glomerular filtration rate and renal plasma flow decline with age (Bender, 1965; Rowe et al., 1976) . It is, therefore, predictable that drugs like alcuronium, which are excreted predominantly by the kidney, will have a prolonged half-life and, in the absence of distributive changes, a decreased clearance in the elderly.
In conclusion, the elimination half-life of alcuronium was prolonged in the elderly, probably because of a decrease in plasma clearance as a result of reduced renal elimination of the drug. Thus, based purely on pharmacokinetic considerations, doses may require appropriate adjustments in normal elderly patients. On the other hand, in patients with extensive haemodilution, the plasma clearance of alcuronium appeared to be unaltered and adjustment of the dose would seem unnecessary. However, a separate study indicated that there was a high frequency of functional renal failure in patients following abdominal aortic surgery (60%), although not in patients undergoing surgery on lower limb arteries. The frequency correlated significantly (P<0.05) with the haemodynamic changes, the amount of blood loss, and the infusion of mannitol during surgery. Severe perioperative haemodynamic changes, blood loss greater than 2 litre, and the infusion of mannitol were found to be good indicators of renal failure after abdominal aortic surgery (Lhoest, Scottiaux and Albert, 1980) . Therefore, high doses of alcuronium might still be used cautiously in patients undergoing aortic reconstructive operations. In addition, one should not ignore the influence of haemodilution on the potency of neuromuscular blocking drugs. A recent study indicated that normovolaemic haemodilution before operation could shift the cumulative dose-response curves of pancuronium and tubocurarine to the left. The increase in the potency of these two neuromuscular blocking drugs was considered to be the result of an increase in cardiac output and a decrease in protein binding (Schuh, 1981) . In the situation of intraoperative normovolaemic haemodilution, whether the pharmacokinetic and pharmacodynamic changes antagonize the effects of each other is still unknown and warrants further study.
